FITB · NYSE · STOCK
Fifth Third Bancorp (FITB) Stock Analysis
$50.63
52W $40.05 – $59.50
64/100
$45.90B
17.1
0.99
⚠
Buy rating, but near-term risk/reward is unfavorable
The long-term recommendation is based on the composite investment score. The near-term risk/reward is based on nearby support and resistance levels. These can differ when a strong company trades close to resistance with support further below.
Is FITB Bullish or Bearish?
Bullish.
Innellis AI committee rates Fifth Third Bancorp (FITB) Buy with a composite score of 64/100
, based on 5 analysts with 100% agreement.
Last updated October 10, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +10.72 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -9.28 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Value Analyst sees a compelling case — price-to-book of 1.4x is a discount to asset value. Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- Price-to-book of 1.4x is a discount to asset value — Value
- Dividend yield of 5.1% pays you to wait — Value
- Revenue growing 58.2% YoY -- genuine top-line momentum — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- EPS declining -5.5% YoY despite any revenue growth — Growth
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 10, 2026
Overall Committee Score
64/100
Agreement
100%
Analysts
5
Conviction
Unanimous
Sector Rank
Top 25%
of 211 Financial Services peers
Value Analyst
bullish
70
/ 100 · Moderate confidence
Classic value case: cheap on multiples with earnings power to back it up
+ Price-to-book of 1.4x is a discount to asset value
Growth Analyst
bullish
63
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ Revenue growing 58.2% YoY -- genuine top-line momentum
− EPS declining -5.5% YoY despite any revenue growth
Technical Analyst
bullish
61
/ 100 · High confidence
Price action is constructive -- trend and momentum agree
+ MACD histogram positive -- bullish momentum
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
bullish
62
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Portfolio Manager
bearish
30
/ 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Investment Thesis Evolution
Committee score moved marginally from 62.8 to 64.3.
- Conviction changed from high to unanimous.
- Committee agreement increased sharply from 80% to 100%.
- New bullish signals: 1 appeared.
- Bearish pressure eased: 1 signal(s) disappeared.
- Analyst(s) changed stance: Technical Analyst.
Analyst-level changes:
- Technical Analyst: stance neutral->bullish; score 54->61 (+8); +1 bullish signal(s).
Comparing 2026-10-09 to 2026-10-10 (1 day apart).
Technical Analysis
RSI (14)
38.4
Neutral
MACD Histogram
0.005
Bullish Momentum
Trend Direction
Sideways
Weekly: Sideways
Market Structure
Mixed
Support
$46.80
Resistance
$51.86
Bollinger %B
0.27
Inside Bands
Price vs Moving Averages
EMA 9
$50.89
Below
EMA 21
$51.84
Below
EMA 50
$53.23
Below
EMA 200
$51.47
Below
Fundamental Analysis
Valuation
97
Growth
57
Profitability
62
Financial Health
46
Cash Flow
70
Valuation
P/E Ratio
17.1×
P/B Ratio
1.34×
PEG Ratio
-2.05
Dividend Yield
3.20%
52W High
$59.50
52W Low
$40.05
Quality & Growth
ROE
1161.4%
ROA
117.7%
Gross Margin
6850.2%
Operating Margin
2011.2%
Revenue Growth YoY
—
Debt / Equity
0.65
AI Fundamental Assessment
P/E ratio of 17.1 (inexpensive relative to a 15-40x range); Price-to-book of 1.3x; PEG ratio of -2.0 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 11.6%; Return on assets of 1.2%; Net margin of 15.8%; Gross margin of 68.5%; Current ratio of 0.37 (tight short-term liquidity); Debt-to-equity of 0.65; Free cash flow per share is positive (3.30); Most recent quarter missed estimates by 12.0%; EPS growth accelerating (-23.6% -> +1.2% QoQ); Average YoY EPS growth of -3.4%; Analyst estimates falling over recent quarters
Get the Full FITB Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →